Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Jun. 30, 2016

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Data

	Three Months Ended
	June 30, 2015		March 31, 2015		December 31, 2014		September 30, 2014
Net sales	$	680,565	$	652,351	$	679,759	$	596,938
Gross profit	$	155,725	$	149,609	$	150,359	$	107,162
Operating income	$	77,339	$	68,154	$	67,997	$	20,372
Income before income taxes and equity in earnings of equity-method investees	$	76,265	$	59,514	$	59,183	$	17,907
Net income	$	72,152	$	38,001	$	39,653	$	15,155
Net income per common share:
Basic	$	0.70	$	0.37	$	0.39	$	0.15
Diluted	$	0.69	$	0.37	$	0.38	$	0.15

See below for a reconciliation of the Company’s fiscal 2016 and 2015 quarterly consolidated statements of income from the previously reported amounts to the revised amounts.

	Three Months Ended
	June 30, 2016			March 31, 2016		December 31, 2015		September 30, 2015
Net sales	$	737,547		$	736,663	$	743,437	$	667,727
Gross profit	$	150,081		$	159,908	$	166,261	$	137,881
Operating income (loss)	$	(65,138	)	$	71,148	$	90,078	$	54,272
Income before income taxes and equity in earnings of equity-method investees	$	(77,572	)	$	72,863	$	80,713	$	42,404
Net income (loss)	$	(88,597	)	$	48,788	$	58,080	$	29,158
Net income (loss) per common share:
Basic	$	(0.86	)	$	0.47	$	0.56	$	0.28
Diluted	$	(0.86	)	$	0.47	$	0.56	$	0.28

Schedule of Correction of Immaterial Errors to Prior Period Financial Statements

The following table summarizes the effect of the corrections on income before income taxes and equity in earnings of equity method investees on the consolidated statement of income for the years ended June 30, 2015 and 2014:

	Fiscal Year Ended June 30,
	2015			2014
Effect of Revenue Corrections	$	(6,214	)	$	(5,982	)
Timing of Tradename Impairment	5,510			(6,399		)
Other Corrections	(1,717		)	1,947
Effect of all corrections on income before income taxes and equity   in earnings of equity-method investees	$	(2,421	)	$	(10,434	)

The following table reconciles the Company’s consolidated balance sheet at June 30, 2015 from the previously reported amounts to the revised amounts:

	June 30, 2015
	As Reported			Adjustment			As Revised
ASSETS
Current assets:
Cash and cash equivalents	$	166,922		$	—		$	166,922
Accounts receivable, less allowance for doubtful accounts of $896	320,197			(57,089		)	263,108
Inventories	382,211			15,108			397,319
Deferred income taxes	20,758			17,748			38,506
Prepaid expenses and other current assets	42,931			20,009			62,940
Total current assets	933,019			(4,224		)	928,795
Property, plant and equipment, net	344,262			9,402			353,664
Goodwill	1,136,079			(401		)	1,135,678
Trademarks and other intangible assets, net	647,754			(1,362		)	646,392
Investments and joint ventures	2,305			—			2,305
Other assets	33,851			(1,277		)	32,574
Total assets	$	3,097,270		$	2,138		$	3,099,408
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	251,999		$	22,448		$	274,447
Accrued expenses and other current liabilities	79,167			6,466			85,633
Current portion of long-term debt	31,275			—			31,275
Total current liabilities	362,441			28,914			391,355
Long-term debt, less current portion	812,608			—			812,608
Deferred income taxes	145,297			5,844			151,141
Other noncurrent liabilities	5,237			11,400			16,637
Total liabilities	1,325,583			46,158			1,371,741
Stockholders’ equity:
Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none	—			—			—
Common stock - $.01 par value, authorized 150,000 shares; issued: 105,841 shares; outstanding: 102,612 shares	1,058			—			1,058
Additional paid-in-capital	1,073,671			(1,244		)	1,072,427
Retained earnings	797,514			(43,551		)	753,963
Accumulated other comprehensive loss	(42,406		)	775			(41,631		)
	1,829,837			(44,020		)	1,785,817
Less: Treasury stock, at cost, 3,229 shares	(58,150		)	—			(58,150		)
Total stockholders’ equity	1,771,687			(44,020		)	1,727,667
Total liabilities and stockholders’ equity	$	3,097,270		$	2,138		$	3,099,408

The following tables reconcile the Company’s fiscal 2015 and 2014 annual consolidated statements of income from the previously reported amounts to the revised amounts:

	Year Ended June 30, 2015									Year Ended June 30, 2014
	As Reported			Adjustment			As Revised			As Reported			Adjustment			As Revised
Net sales	$	2,688,515		$	(78,902	)	$	2,609,613		$	2,153,611		$	(45,789	)	$	2,107,822
Cost of sales	2,069,898			(23,140		)	2,046,758			1,586,418			(6,878		)	1,579,540
Gross profit	618,617			(55,762		)	562,855			567,193			(38,911		)	528,282
Selling, general and administrative expenses	348,517			(45,690		)	302,827			311,288			(31,778		)	279,510
Amortization of acquired intangibles	17,985			(139		)	17,846			15,600			(160		)	15,440
Tradename impairment	5,510			(5,510		)	—			—			6,399			6,399
Acquisition related expenses, restructuring and integration charges	8,860			(540		)	8,320			12,568			(2,381		)	10,187
Operating income	237,745			(3,883		)	233,862			227,737			(10,991		)	216,746
Interest and other financing expense, net	26,022			(49		)	25,973			24,691			(325		)	24,366
Other (income)/expense, net	4,689			—			4,689			(4,548		)	(232		)	(4,780		)
Gain on sale of business	(8,256		)	(1,413		)	(9,669		)	—			—			—
Income before income taxes and equity in earnings of equity-method investees	215,290			(2,421		)	212,869			207,594			(10,434		)	197,160
Provision for income taxes	47,883			652			48,535			70,099			(491		)	69,608
Equity in net loss of equity-method investees	(489		)	(139		)	(628		)	(3,985		)	(14		)	(3,999		)
Income from continuing operations	167,896			(2,934		)	164,962			141,480			(9,929		)	131,551
Loss from discontinued operations, net of tax	—			—			—			(1,629		)	—			(1,629		)
Net income	$	167,896		$	(2,934	)	$	164,962		$	139,851		$	(9,929	)	$	129,922
Basic net income (loss) per common share:
From continuing operations	$	1.65		$	(0.03	)	$	1.62		$	1.45		$	(0.10	)	$	1.35
From discontinued operations	—			—			—			(0.02		)	—			(0.02		)
Net income per common share - basic	$	1.65		$	(0.03	)	$	1.62		$	1.43		$	(0.10	)	$	1.33
Diluted net income (loss) per common share:
From continuing operations	$	1.62		$	(0.03	)	$	1.60		$	1.42		$	(0.10	)	$	1.32
From discontinued operations	—			—			—			(0.02		)	—			(0.02		)
Net income per common share - diluted	$	1.62		$	(0.03	)	$	1.60		$	1.40		$	(0.10	)	$	1.30
Shares used in the calculation of net income per common share:
Basic	101,703			101,703			101,703			97,750			97,750			97,750
Diluted	103,421			103,421			103,421			100,006			100,006			100,006

Net income/(loss) per common share may not add in certain periods due to rounding

The following table reconciles the Company’s fiscal 2015 and 2014 annual consolidated statements of comprehensive income (loss) from the previously reported amounts to the revised amounts:

	Fiscal Year Ended June 30, 2015									Fiscal Year Ended June 30, 2014
	As Reported			Adjustment			As Revised			As Reported			Adjustment			As Revised
Net income	$	167,896		$	(2,934	)	$	164,962		$	139,851		$	(9,929	)	$	129,922
Other comprehensive income (loss):
Foreign currency translation adjustments	(103,209		)	835			(102,374		)	90,625			148			90,773
Change in deferred gains (losses) on cash flow hedging instruments	1,581			—			1,581			(1,404		)	—			(1,404		)
Change in unrealized loss on available for sale investment	(906		)	—			(906		)	(1,842		)	—			(1,842		)
Total other comprehensive (loss) income	(102,534		)	835			(101,699		)	87,379			148			87,527
Total comprehensive income	$	65,362		$	(2,099	)	$	63,263		$	227,230		$	(9,781	)	$	217,449

The following table reconciles the Company’s fiscal 2015 and 2014 annual cash flows from operating activities from the previously reported amounts to the revised amounts:

	Fiscal Year Ended June 30, 2015									Fiscal Year Ended June 30, 2014
	As Reported			Adjustment			As Revised			As Reported			Adjustment			As Revised
Net income	$	167,896		$	(2,934	)	$	164,962		$	139,851		$	(9,929	)	$	129,922
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	56,587			793			57,380			48,040			182			48,222
Deferred income taxes	(11,603		)	8,936			(2,667		)	(1,350		)	(1,262		)	(2,612		)
Equity in net income of equity-method investees	(489		)	(139		)	(628		)	(3,985		)	(14		)	(3,999		)
Stock based compensation	12,197			—			12,197			12,448			—			12,448
Contingent consideration expense	280			(533		)	(253		)	(3,026		)	2,043			(983		)
Loss on sale of business	—			—			—			1,629			—			1,629
Gains on pre-existing ownership interests in HPPC and Empire	(8,256		)	(1,413		)	(9,669		)	—			—			—
Impairment charges	5,510			(5,510		)	—			—			7,504			7,504
Other non-cash items, net	(1,428		)	(6		)	(1,434		)	1,175			—			1,175
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net
Accounts receivable	(31,846		)	12,264			(19,582		)	967			11,628			12,595
Inventories	(21,097		)	(9,368		)	(30,465		)	(22,775		)	(2,044		)	(24,819		)
Other current assets	7,699			(23,007		)	(15,308		)	(7,948		)	(8,055		)	(16,003		)
Other assets and liabilities	(3,964		)	—			(3,964		)	(5,540		)	4,997			(543		)
Accounts payable and accrued expenses	13,996			20,917			34,913			25,282			(5,050		)	20,232
Net cash provided by operating activities	$	185,482		$	—		$	185,482		$	184,768		$	—		$	184,768

The following table reconciles the Company’s fiscal 2013, 2014 and 2015 annual consolidated statements of stockholders’ equity from the previously reported amounts to the revised amounts:

	Common Stock			Additional										Accumulated Other
		Amount		Paid-in			Retained			Treasury Stock				Comprehensive
	Shares	at $.01		Capital			Earnings			Shares	Amount			Income (Loss)			Total
Balance at June 30, 2013, as reported	98,044	$	980	$	768,284		$	489,767		2,672	$	(30,225	)	$	(27,251	)	$	1,201,555
Adjustment	—	—		—			(30,688		)	—	—			(208		)	(30,896		)
Balance at June 30, 2013, as revised	98,044	$	980	$	768,284		$	459,079		2,672	$	(30,225	)	$	(27,459	)	$	1,170,659
Balance at June 30, 2014, as reported	103,143	$	1,031	$	969,182		$	629,618		2,906	$	(40,092	)	$	60,128		$	1,619,867
Adjustment	—	—		1,635			(40,617		)	—	—			(60		)	(39,042		)
Balance at June 30, 2014, as revised	103,143	$	1,031	$	970,817		$	589,001		2,906	$	(40,092	)	$	60,068		$	1,580,825
Balance at June 30, 2015, as reported	105,841	$	1,058	$	1,073,671		$	797,514		3,229	$	(58,150	)	$	(42,406	)	$	1,771,687
Adjustment	—	—		(1,244		)	(43,551		)	—	—			775			(44,020		)
Balance at June 30, 2015, as revised	105,841	$	1,058	$	1,072,427		$	753,963		3,229	$	(58,150	)	$	(41,631	)	$	1,727,667

Note: The common stock and additional paid-in capital amounts and the treasury shares for the fiscal year ended June 30, 2014 have been retroactively adjusted to reflect a two-for-one stock split of the Company’s common stock in the form of a 100% stock dividend.

The following table reconciles the Company’s fiscal 2015 and 2014 annual segment net sales and operating income data from the previously reported amounts to the revised amounts:

	Fiscal Year Ended June 30, 2015									Fiscal Year Ended June 30, 2014
	As Reported			Adjustment			As Revised			As Reported			Adjustment			As Revised
Net Sales:
United States	$	1,367,388		$	(41,392	)	$	1,325,996		$	1,282,175		$	(35,062	)	$	1,247,113
United Kingdom	735,996			(13,166		)	722,830			637,454			(8,626		)	628,828
Hain Pure Protein	358,582			(21,385		)	337,197			—			—			—
Rest of World	226,549			(2,959		)	223,590			233,982			(2,101		)	231,881
	$	2,688,515		$	(78,902	)	$	2,609,613		$	2,153,611		$	(45,789	)	$	2,107,822
Operating Income:
United States	$	199,901		$	(11,847	)	$	188,054		$	205,864		$	(4,801	)	$	201,063
United Kingdom	46,222			(1,237		)	44,985			52,661			(3,152		)	49,509
Hain Pure Protein	26,479			2,206			28,685			—			—			—
Rest of World	16,438			(1,228		)	15,210			16,931			(182		)	16,749
	$	289,040		$	(12,106	)	$	276,934		$	275,456		$	(8,135	)	$	267,321
Corporate and Other	(51,295		)	8,223			(43,072		)	(47,719		)	(2,856		)	(50,575		)
	$	237,745		$	(3,883	)	$	233,862		$	227,737		$	(10,991	)	$	216,746

The following tables reconcile the Company’s fiscal 2016 and 2015 quarterly consolidated statements of income from the previously reported amounts to the revised amounts:

	Three Months Ended
	March 31, 2016									December 31, 2015							September 30, 2015
	As Reported			Adjustment			As Revised			As Reported		Adjustment			As Revised		As Reported			Adjustment			As Revised
Net sales	$	749,862		$	(13,199	)	$	736,663		$	752,589	$	(9,152	)	$	743,437	$	687,188		$	(19,461	)	$	667,727
Cost of sales	576,653			102			576,755			575,026		2,150			577,176		535,141			(5,295		)	529,846
Gross profit	173,209			(13,301		)	159,908			177,563		(11,302		)	166,261		152,047			(14,166		)	137,881
Selling, general and   administrative   expenses	93,915			(15,025		)	78,890			82,607		(13,626		)	68,981		86,254			(10,704		)	75,550
Amortization of   acquired intangibles	4,586			(33		)	4,553			4,736		(32		)	4,704		4,672			(33		)	4,639
Acquisition related   expenses,   restructuring   and integration   charges	5,701			(384		)	5,317			2,498		—			2,498		3,653			(233		)	3,420
Operating income	69,007			2,141			71,148			87,722		2,356			90,078		57,468			(3,196		)	54,272
Interest and other   financing expense,   net	6,920			—			6,920			6,131		—			6,131		6,467			—			6,467
Other (income)/   expense, net	378			—			378			3,234		—			3,234		5,401			—			5,401
Gain on fire insurance   recovery	(9,013		)	—			(9,013		)	—		—			—		—			—			—
Income before income   taxes and equity in   earnings of equity-   method investees	70,722			2,141			72,863			78,357		2,356			80,713		45,600			(3,196		)	42,404
Provision for income   taxes	21,576			2,338			23,914			21,379		1,223			22,602		14,382			(1,052		)	13,330
Equity in net income   of equity-method   investees	161			—			161			31		—			31		(84		)	—			(84		)
Net income	$	48,985		$	(197	)	$	48,788		$	56,947	$	1,133		$	58,080	$	31,302		$	(2,144	)	$	29,158
Net income per   common share:
Basic	$	0.47		$	—		$	0.47		$	0.55	$	0.01		$	0.56	$	0.30		$	(0.02	)	$	0.28
Diluted	$	0.47		$	—		$	0.47		$	0.55	$	0.01		$	0.56	$	0.30		$	(0.02	)	$	0.28
Weighted average   common shares   outstanding:
Basic	103,265			103,265			103,265			103,017		103,017			103,017		102,807			102,807			102,807
Diluted	104,087			104,087			104,087			104,161		104,161			104,161		104,258			104,258			104,258

* Net income/(loss) per common share may not add in certain periods due to rounding

	Three Months Ended
	June 30, 2015									March 31, 2015
	As Reported			Adjustment			As Revised			As Reported			Adjustment			As Revised
Net sales	$	698,136		$	(17,571	)	$	680,565		$	662,739		$	(10,388	)	$	652,351
Cost of sales	530,439			(5,599		)	524,840			504,990			(2,248		)	502,742
Gross profit	167,697			(11,972		)	155,725			157,749			(8,140		)	149,609
Selling, general and administrative expenses	85,904			(14,567		)	71,337			83,068			(10,558		)	72,510
Amortization of acquired intangibles	4,494			(32		)	4,462			4,679			(32		)	4,647
Tradename impairment	—			—			—			5,510			(5,510		)	—
Acquisition related expenses, restructuring and integration   charges	2,587			—			2,587			4,298			—			4,298
Operating income	74,712			2,627			77,339			60,194			7,960			68,154
Interest and other financing expense, net	6,420			—			6,420			6,298			—			6,298
Other (income)/expense, net	(3,968		)	—			(3,968		)	3,886			—			3,886
Gain on sale of business	(1,378		)	—			(1,378		)	(1,544		)	—			(1,544		)
Income before income taxes and equity in   earnings of equity-method investees	73,638			2,627			76,265			51,554			7,960			59,514
Provision for income taxes	2,740			1,547			4,287			18,147			3,353			21,500
Equity in net income (loss) of equity-method investees	(174		)	—			(174		)	13			—			13
Net income	$	71,072		$	1,080		$	72,152		$	33,394		$	4,607		$	38,001
Net income per common share:
Basic	$	0.69		$	0.01		$	0.70		$	0.33		$	0.05		$	0.37
Diluted	$	0.68		$	0.01		$	0.69		$	0.32		$	0.04		$	0.37
Weighted average common shares outstanding:
Basic	102,610			102,610			102,610			102,252			102,252			102,252
Diluted	104,005			104,005			104,005			103,796			103,796			103,796

* Net income/(loss) per common share may not add in certain periods due to rounding

	Three Months Ended
	December 31, 2014									September 31, 2014
	As Reported			Adjustment			As Revised			As Reported			Adjustment			As Revised
Net sales	$	696,383		$	(16,624	)	$	679,759		$	631,257		$	(34,319	)	$	596,938
Cost of sales	529,056			344			529,400			505,413			(15,637		)	489,776
Gross profit	167,327			(16,968		)	150,359			125,844			(18,682		)	107,162
Selling, general and administrative expenses	88,621			(10,377		)	78,244			90,924			(10,189		)	80,735
Amortization of acquired intangibles	4,303			(36		)	4,267			4,509			(38		)	4,471
Tradename impairment	—			—			—			—			—			—
Acquisition related expenses, restructuring and   integration charges	391			(540		)	(149		)	1,584			—			1,584
Operating income	74,012			(6,015		)	67,997			28,827			(8,455		)	20,372
Interest and other financing expense, net	6,542			—			6,542			6,762			(49		)	6,713
Other expense, net	2,272			—			2,272			2,499			—			2,499
Gain on sale of business	—			—			—			(5,334		)	(1,413		)	(6,747		)
Income before income taxes and equity in   earnings of equity-method investees	65,198			(6,015		)	59,183			24,900			(6,993		)	17,907
Provision for income taxes	20,931			(1,093		)	19,838			6,065			(3,154		)	2,911
Equity in net loss of equity-method investees	(308		)	—			(308		)	(20		)	(139		)	(159		)
Net income	$	44,575		$	(4,922	)	$	39,653		$	18,855		$	(3,700	)	$	15,155
Net income per common share:
Basic	$	0.44		$	(0.05	)	$	0.39		$	0.19		$	(0.04	)	$	0.15
Diluted	$	0.43		$	(0.05	)	$	0.38		$	0.18		$	(0.04	)	$	0.15
Weighted average common shares outstanding:
Basic	101,267			101,267			101,267			100,682			100,682			100,682
Diluted	103,226			103,226			103,226			102,656			102,656			102,656

* Net income/(loss) per common share may not add in certain periods due to rounding